Fewer adverse events reported in ATTR-CM patients treated with vutrisiran versus placebo: Post hoc safety analysis from HELIOS-B
30 August 2026 (09:15 - 10:00)
Organised by: 
About the speaker
Ludwig Maximilians University, Munich (Germany)
6 More presentations in this session
Associate Professor M. Crespo-Leiro (A Coruna, ES)
Doctor S. Perlini (Pavia, IT)
Doctor T. Zaizen (Oita, JP)
Assistant Professor K. Yoshie (Matsumoto, JP)
Doctor F. Aus Dem Siepen (Heidelberg, DE)
Access the full session
The Event
ESC Congress 2026
30 August 2026
09:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
